FRAMINGHAM, Mass., Nov. 12, 2015 /PRNewswire/ -- HeartWare
International, Inc. (NASDAQ:HTWR), a leading innovator of
less-invasive, miniaturized circulatory support technologies that
are revolutionizing the treatment of advanced heart failure, today
announced that HeartWare President and Chief Executive Officer,
Doug Godshall, is scheduled to
present at the Canaccord Genuity 2015 Medical Technology &
Diagnostics Forum on November 19,
2015 at 10:00 a.m. ET in
New York.
A live webcast of the company's presentation at the conference
will be available via a link provided at www.heartware.com. A
replay of the webcast will be available for 90 days after the
presentation.
About HeartWare International
HeartWare International,
Inc. develops and manufactures miniaturized implantable heart
pumps, or ventricular assist devices, to treat patients suffering
from advanced heart failure. The HeartWare® Ventricular
Assist System features the HVAD® pump, a small
full-support circulatory assist device designed to be implanted
next to the heart, avoiding the abdominal surgery generally
required to implant competing devices. The HeartWare HVAD System is
approved in the United States for
the intended use as a bridge to cardiac transplantation in patients
who are at risk of death from refractory end-stage left ventricular
heart failure, has received CE Marking in the European Union and
has been used to treat patients in 47 countries. The device is also
currently the subject of a U.S. clinical trial for destination
therapy. For additional information, please visit
www.heartware.com.
HeartWare International, Inc. is a member of the Russell
2000®, and its securities are publicly traded on The
NASDAQ Stock Market.
HEARTWARE, HVAD, MVAD, PAL, SYNERGY, CIRCULITE and HeartWare
logos are trademarks of HeartWare, Inc. or its
affiliates.
For additional information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartware.com
Phone: +1 508 739 0864
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/heartware-presentation-at-the-canaccord-genuity-2015-medical-technology--diagnostics-forum-to-be-webcast-300177399.html
SOURCE HeartWare International, Inc.